Artículo
Biology of Small cell lung cancer: State of art and novel perspectives
Denninghoff, Valeria Cecilia
; Russo, Alessandro; de Miguel Perez, Diego; Malapelle, Umberto; Benyounes, Amin; Gittens, Allison; Cardona, Andrés Felipe; Rolfo, Christian
Fecha de publicación:
03/2021
Editorial:
Multidisciplinary Digital Publishing Institute
Revista:
Cancers
ISSN:
2072-6694
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Small cell lung cancer (SCLC) is a highly proliferative lung cancer that is not amenable to surgery in most cases due to the high metastatic potential. Precision medicine has not yet improved patients’ survival due to the lack of actionable mutations. Intra- and intertumoral heterogeneity allow the neoplasms to adapt to various microenvironments and treatments. Further studying this heterogeneous cancer might yield the discovery of actionable mutations. First-line SCLC treatment has added immunotherapy to its armamentarium. There has been renewed interest in SCLC, and numerous clinical trials are underway with novel therapeutic approaches. Understanding the molecular and genetic landscape of this heterogeneous and lethal disease will pave the way for novel drug development.
Palabras clave:
SMALL CELL LUNG CANCER
,
GENE PATHWAY
,
PATHOBIOLOGY
,
TARGET THERAPY
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Denninghoff, Valeria Cecilia; Russo, Alessandro; de Miguel Perez, Diego; Malapelle, Umberto; Benyounes, Amin; et al.; Biology of Small cell lung cancer: State of art and novel perspectives; Multidisciplinary Digital Publishing Institute; Cancers; 13; 7; 3-2021; 1-12
Compartir
Altmétricas